Ultragenyx Pharmaceutical Inc. (RARE): Price and Financial Metrics
Ultragenyx Pharmaceutical Inc. (RARE)
Today's Latest Price: $73.81 USD
3.32 (4.71%)
Updated May 22 4:00pm
Add RARE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
RARE Stock Summary
- For RARE, its debt to operating expenses ratio is greater than that reported by merely 9.65% of US equities we're observing.
- With a price/sales ratio of 36.19, Ultragenyx Pharmaceutical Inc has a higher such ratio than 95.65% of stocks in our set.
- Revenue growth over the past 12 months for Ultragenyx Pharmaceutical Inc comes in at 106.56%, a number that bests 94.89% of the US stocks we're tracking.
- Stocks that are quantitatively similar to RARE, based on their financial statements, market capitalization, and price volatility, are RGNX, APTX, FPRX, MEIP, and AGIO.
- RARE's SEC filings can be seen here. And to visit Ultragenyx Pharmaceutical Inc's official web site, go to www.ultragenyx.com.
RARE Daily Price Range
RARE 52-Week Price Range
RARE Stock Price Chart More Charts
RARE Price/Volume Stats
| Current price | $73.81 | 52-week high | $76.00 |
| Prev. close | $70.49 | 52-week low | $31.99 |
| Day low | $70.20 | Volume | 482,991 |
| Day high | $74.08 | Avg. volume | 581,472 |
| 50-day MA | $56.19 | Dividend yield | N/A |
| 200-day MA | $50.03 | Market Cap | 4.40B |
Ultragenyx Pharmaceutical Inc. (RARE) Company Bio
Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company was founded in 2010 and is based in Novato, California.
Loading social stream, please wait...